The Office of Cancer Clinical Proteomics Research of the National Cancer Institute (NCI), part of the National Institutes of Health, announces the release of a video titled, “International Cancer Proteogenome Consortium (ICPC)”. Launched during the 2018 Human Proteome Organization World Congress, the video is a call-to-action for both current and potential consortium members to share data and develop a cancer atlas representative of the diversity of people with cancer around the world.
Inspired by the Cancer Moonshot, ICPC adopts an emerging science and technology called proteogenomics, which combines genomics with next-generation proteomics and has been successfully pioneered by the Clinical Proteomic Tumor Analysis Consortium. Since 2016, ICPC spans 12 countries and involves 31 institutions conducting research on over a dozen cancer types. More recently, the Taiwan team transferred ICPC’s first data set to NCI, piloted a student exchange training program, and welcomed two Indian institutes to the consortium. Visit NCI’s YouTube Channel to watch the video and the ICPC webpage to learn more about the program.